Compare BGDE & ESLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BGDE | ESLA |
|---|---|---|
| Founded | N/A | 2021 |
| Country | Australia | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 47.4M | 45.6M |
| IPO Year | N/A | N/A |
| Metric | BGDE | ESLA |
|---|---|---|
| Price | $7.42 | $0.97 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $8.00 |
| AVG Volume (30 Days) | ★ 129.9K | 43.0K |
| Earning Date | N/A | 05-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $7.15 | $0.78 |
| 52 Week High | $11.69 | $3.15 |
| Indicator | BGDE | ESLA |
|---|---|---|
| Relative Strength Index (RSI) | 5.74 | 41.07 |
| Support Level | N/A | $0.97 |
| Resistance Level | N/A | $1.28 |
| Average True Range (ATR) | 1.25 | 0.08 |
| MACD | -0.34 | 0.01 |
| Stochastic Oscillator | 6.61 | 39.29 |
Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors.